Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Free Cash Flow (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Free Cash Flow for 11 consecutive years, with $12973.0 as the latest value for Q3 2025.

  • On a quarterly basis, Free Cash Flow rose 100.65% to $12973.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$173904.0, a 89.77% increase, with the full-year FY2024 number at -$1.6 million, up 71.51% from a year prior.
  • Free Cash Flow was $12973.0 for Q3 2025 at KORU Medical Systems, up from -$489154.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $1.1 million in Q4 2022 to a low of -$4.9 million in Q1 2023.
  • A 5-year average of -$1.1 million and a median of -$680905.0 in 2025 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: plummeted 5135.19% in 2021, then soared 246.68% in 2022.
  • KORU Medical Systems' Free Cash Flow stood at -$761590.0 in 2021, then skyrocketed by 246.68% to $1.1 million in 2022, then dropped by 19.37% to $900753.0 in 2023, then rose by 9.15% to $983182.0 in 2024, then tumbled by 98.68% to $12973.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Free Cash Flow are $12973.0 (Q3 2025), -$489154.0 (Q2 2025), and -$680905.0 (Q1 2025).